(XTLB) Xtl Biopharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xtl Biopharmaceuticals | (XTLB) share price targets
Complete technical analysis of Xtl Biopharmaceuticals (XTLB) by charts plus indicators, forecast predictions and share price targets for Xtl Biopharmaceuticals (XTLB)
Xtl Biopharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-25 View latest technical analysis
10 day averaged volume of Xtl Biopharmaceuticals is 38230
Date | Daily Closing Price | Open | High | Low | Volume |
25 Tue Jun 2024 | 2.30 | 2.30 | 2.30 | 2.30 | 0.016 times |
24 Mon Jun 2024 | 2.22 | 2.31 | 2.31 | 2.22 | 0.052 times |
21 Fri Jun 2024 | 2.24 | 2.34 | 2.34 | 2.20 | 0.06 times |
20 Thu Jun 2024 | 2.29 | 2.45 | 2.47 | 2.16 | 0.371 times |
18 Tue Jun 2024 | 2.48 | 2.55 | 2.81 | 2.44 | 1.729 times |
18 Tue Jun 2024 | 2.48 | 2.55 | 2.81 | 2.44 | 1.729 times |
17 Mon Jun 2024 | 2.44 | 2.35 | 2.44 | 2.27 | 3.136 times |
14 Fri Jun 2024 | 2.04 | 2.18 | 2.18 | 2.02 | 0.241 times |
13 Thu Jun 2024 | 2.18 | 2.16 | 2.24 | 2.14 | 0.654 times |
12 Wed Jun 2024 | 2.15 | 2.10 | 2.15 | 1.97 | 0.309 times |
My analysis of stock is bearish for shortterm, and stock might move down till 2.2 or till 1.9. Use a stoploss of 2.36 and if the stock hits stoploss, then it can shoot up till 2.55
Share price targets for Xtl Biopharmaceuticals (XTLB)
Target Type | Value |
Downside Target | 0.77 |
Downside Target | 0.85 |
Downside Target | 0.95 |
Downside Target | 1.85 |
Downside Target | 2.10 |
Downside Target | 2.16 |
Downside Target | 2.27 |
Upside Target | 2.64 |
Upside Target | 2.81 |
Upside Target | 3.15 |
Upside Target | 3.48 |
Upside Target | 4.99 |
Intraday share price targets for Xtl Biopharmaceuticals (XTLB)
Target Type | Value |
Downside Intraday Target | 2.24 |
Downside Intraday Target | 2.19 |
Upside Intraday Target | 2.33 |
Upside Intraday Target | 2.37 |
Downside Intraday Target | 2.28 |
Weekly technical analysis of Xtl Biopharmaceuticals (XTLB)
Date | Weekly Closing Price | Open | High | Low | Volume |
25 Tue Jun 2024 | 2.30 | 2.31 | 2.31 | 2.22 | 0.031 times |
21 Fri Jun 2024 | 2.24 | 2.55 | 2.81 | 2.16 | 0.444 times |
18 Tue Jun 2024 | 2.48 | 2.35 | 2.81 | 2.27 | 1.133 times |
14 Fri Jun 2024 | 2.04 | 2.23 | 2.32 | 1.85 | 1.29 times |
07 Fri Jun 2024 | 2.27 | 2.57 | 2.64 | 2.20 | 2.21 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Xtl Biopharmaceuticals (XTLB)
Date | Monthly Closing Price | Open | High | Low | Volume |
25 Tue Jun 2024 | 2.30 | 2.57 | 2.81 | 1.85 | 2.155 times |
31 Fri May 2024 | 2.64 | 2.53 | 3.15 | 2.10 | 0.127 times |
30 Tue Apr 2024 | 2.59 | 2.75 | 3.48 | 2.35 | 0.046 times |
28 Thu Mar 2024 | 2.81 | 0.90 | 4.99 | 0.85 | 1145.546 times |
Scroll below to view daily charts
Price has moved down this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Xtl Biopharmaceuticals (XTLB)
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Xtl Biopharmaceuticals in short term and the sell signal is strong.
Xtl Biopharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Xtl Biopharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Xtl Biopharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.4 and Xtl Biopharmaceuticals (XTLB) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Xtl Biopharmaceuticals (XTLB) stock. Volume based technical analysis of Xtl Biopharmaceuticals (XTLB) stock is negative.
Xtl Biopharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Xtl Biopharmaceuticals in short term and the sell signal is strong.
Xtl Biopharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Xtl Biopharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Xtl Biopharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.4 and Xtl Biopharmaceuticals (XTLB) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Xtl Biopharmaceuticals (XTLB) stock. Volume based technical analysis of Xtl Biopharmaceuticals (XTLB) stock is negative.
Xtl Biopharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.